Basit öğe kaydını göster

dc.contributor.authorArslan, Birsen Y.
dc.contributor.authorKaragöz, Ergenekon
dc.contributor.authorArslan, Ferhat
dc.date.accessioned08.07.201910:49:13
dc.date.accessioned2019-07-08T20:18:51Z
dc.date.available08.07.201910:49:13
dc.date.available2019-07-08T20:18:51Z
dc.date.issued2016en_US
dc.identifier.citationArslan, B., Karagöz, E. ve Arslan, F. (2016). Daptomycin use in mrsa bacteremia of a patient with myasthenia gravis: A case report. Medicine Science, 5(Supplement1), 96-98.en_US
dc.identifier.issn2147-0634
dc.identifier.urihttps://hdl.handle.net/20.500.12511/511
dc.description.abstractMyasthenia gravis (MG) is the most common autoimmune disease affecting the neuromuscular junction and is characterized by ocular, bulbar, limb and respiratory muscle involvement. Some of the drugs may induce and exacerbate MG. Antibiotics are also one of the most important medication groups that may worsen MG and they should be used with caution in these patients with MG. Herein, we would like to share our experience about daptomycin use in Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia of a patient with myasthenia gravis.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectMyasthenia Gravisen_US
dc.subjectBacteremiaen_US
dc.subjectDaptomycinen_US
dc.titleDaptomycin use in mrsa bacteremia of a patient with myasthenia gravis: A case reporten_US
dc.typearticleen_US
dc.relation.ispartofMedicine Scienceen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalıen_US
dc.authorid0000-0001-8554-7651en_US
dc.identifier.volume5en_US
dc.identifier.issueSupplement 1en_US
dc.identifier.startpage96en_US
dc.identifier.endpage98en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster